114
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

Dopamine DRD2 polymorphism (DRD2/ANNK1-Taq1A) is not a significant risk factor in writer’s cramp

, , , , &
Pages 276-279 | Received 10 Feb 2016, Accepted 12 Sep 2016, Published online: 04 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yingfeng Deng, Jianping Huang, Huijun Zhang, Xueqin Zhu & Qin Gong. (2018) Association of expression of DRD2 rs1800497 polymorphism with migraine risk in Han Chinese individuals. Journal of Pain Research 11, pages 763-769.
Read now

Articles from other publishers (2)

Kirsten E. Zeuner, Alexander Baumann & Karsten Witt. (2023) Treatment of writer’s cramp based on current pathophysiological concepts. Dystonia 2.
Crossref
Bastien Ribot, Jérome Aupy, Marie Vidailhet, Joachim Mazère, Antonio Pisani, Erwan Bezard, Dominique Guehl & Pierre Burbaud. (2019) Dystonia and dopamine: From phenomenology to pathophysiology. Progress in Neurobiology 182, pages 101678.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.